Results 1 to 10 of about 200,853 (296)

Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial [PDF]

open access: yesTumor Biology, 2017
Despite initial responsiveness, acquired resistance to both bevacizumab and chemotherapy in metastatic colorectal cancer is universal. We have recently published that in vitro, chronically oxaliplatin resistance upregulates soluble vascular endothelial ...
Estela Pineda   +19 more
doaj   +3 more sources

Hepatocyte Growth Factor and Cardiac Amyloidosis∗

open access: yesJACC. CardioOncology, 2020
[Figure: see text]
Frederick L. Ruberg, MD   +1 more
doaj   +3 more sources

Hepatocyte Growth Factor Differentially Modulates Oral Microbiota in Early vs. Late Experimental Periodontitis [PDF]

open access: yesBiology
Background: Periodontitis is a chronic disease triggered by disturbed oral microbiota. We have previously reported that hepatocyte growth factor (HGF) could mitigate early-stage experimental periodontitis but exacerbate the condition in its late stage ...
Ruotong Ji   +5 more
doaj   +2 more sources

Function of hepatocyte spheroids in bioactive microcapsules is enhanced by endogenous and exogenous hepatocyte growth factor [PDF]

open access: yesBioactive Materials, 2023
The ability to maintain functional hepatocytes has important implications for bioartificial liver development, cell-based therapies, drug screening, and tissue engineering. Several approaches can be used to restore hepatocyte function in vitro, including
Kihak Gwon   +13 more
doaj   +2 more sources

Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac Amyloidosis. [PDF]

open access: yesJACC Adv
Holt MF   +16 more
europepmc   +2 more sources

Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients. [PDF]

open access: yesPLoS ONE, 2012
Interferon-β is a first-line therapy used to prevent relapses in relapsing-remitting multiple sclerosis. The clinical benefit of interferon-β in relapsing-remitting multiple sclerosis is attributed to its immunomodulatory effects on inflammatory ...
Nicolas Molnarfi   +4 more
doaj   +1 more source

A single injection of CM1021, a long half-life hepatocyte growth factor mimetic, increases liver mass in mice

open access: yesBiochemistry and Biophysics Reports, 2021
Despite years of positive animal data, hepatocyte growth factor (HGF) has never been developed into a useful pharmaceutical, primarily due to its poor pharmacological properties. CM1021 is a fusion protein containing the K1 loop of HGF and the human IgG1
James H. Kelly
doaj   +1 more source

Hepatocyte growth factor pathway expression in breast cancer by race and subtype

open access: yesBreast Cancer Research, 2021
Background African American women have the highest risk of breast cancer mortality compared to other racial groups. Differences in tumor characteristics have been implicated as a possible cause; however, the tumor microenvironment may also contribute to ...
Gieira S. Jones   +11 more
doaj   +1 more source

The relationship between clinical parameters and hepatocyte growth factor/c-Met levels in the sperm of infertile males

open access: yesJournal of Men's Health, 2022
Objective: Hepatocyte growth factor is a pleiotropic cytokine with potent mitogenic activity in many organs and tissues. The receptor for hepatocyte growth factor is c-Met, a transmembrane glycoprotein with tyrosine kinase activity.
Basak Ozge Kayan   +5 more
doaj   +1 more source

Hepatocyte growth factor

open access: yesHepatology, 1992
The two papers in this issue of Hepatology (1, 2) dealing with hepatocyte growth factor (HGF) underscore the increasing importance of this novel growth factor in relation to hepatic growth biology. The emerging literature has already established HGF as a growth factor with potential importance not only for the liver but for ...
G K, Michalopoulos, R, Zarnegav
openaire   +4 more sources

Home - About - Disclaimer - Privacy